These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26222060)

  • 1. Survival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants.
    Thaden JT; Ericson JE; Cross H; Bergin SP; Messina JA; Fowler VG; Benjamin DK; Clark RH; Hornik CP; Smith PB;
    Pediatr Infect Dis J; 2015 Nov; 34(11):1175-9. PubMed ID: 26222060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants.
    Ericson JE; Thaden J; Cross HR; Clark RH; Fowler VG; Benjamin DK; Cohen-Wolkowiez M; Hornik CP; Smith PB;
    Pediatr Infect Dis J; 2015 Apr; 34(4):371-5. PubMed ID: 25760564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus.
    Harbarth S; Rutschmann O; Sudre P; Pittet D
    Arch Intern Med; 1998 Jan; 158(2):182-9. PubMed ID: 9448557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-Susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable
    Jones D; Elshaboury RH; Munson E; Dilworth TJ
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038267
    [No Abstract]   [Full Text] [Related]  

  • 5. Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.
    Bergin SP; Thaden JT; Ericson JE; Cross H; Messina J; Clark RH; Fowler VG; Benjamin DK; Hornik CP; Smith PB;
    Pediatr Infect Dis J; 2015 Sep; 34(9):933-6. PubMed ID: 26065862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.
    Ammerlaan H; Seifert H; Harbarth S; Brun-Buisson C; Torres A; Antonelli M; Kluytmans J; Bonten M;
    Clin Infect Dis; 2009 Oct; 49(7):997-1005. PubMed ID: 19719417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss.
    Herzke CA; Chen LF; Anderson DJ; Choi Y; Sexton DJ; Kaye KS
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1057-61. PubMed ID: 19803766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants.
    Shane AL; Hansen NI; Stoll BJ; Bell EF; Sánchez PJ; Shankaran S; Laptook AR; Das A; Walsh MC; Hale EC; Newman NS; Schrag SJ; Higgins RD;
    Pediatrics; 2012 Apr; 129(4):e914-22. PubMed ID: 22412036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.
    Paul M; Kariv G; Goldberg E; Raskin M; Shaked H; Hazzan R; Samra Z; Paghis D; Bishara J; Leibovici L
    J Antimicrob Chemother; 2010 Dec; 65(12):2658-65. PubMed ID: 20947620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of community-acquired methicillin-resistant Staphylococcus aureus bacteremia to other staphylococcal species in a neonatal intensive care unit.
    Kuint J; Barzilai A; Regev-Yochay G; Rubinstein E; Keller N; Maayan-Metzger A
    Eur J Pediatr; 2007 Apr; 166(4):319-25. PubMed ID: 17051356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.
    Joo J; Yamaki J; Lou M; Hshieh S; Chu T; Shriner KA; Wong-Beringer A
    Clin Ther; 2013 Jul; 35(7):995-1004. PubMed ID: 23829982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012.
    Simor AE; Pelude L; Golding G; Fernandes R; Bryce E; Frenette C; Gravel D; Katz K; McGeer A; Mulvey MR; Smith S; Weiss K;
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):390-7. PubMed ID: 26782274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical predictors of methicillin-resistance and their impact on mortality associated with Staphylococcus aureus bacteraemia.
    Wi YM; Rhee JY; Kang CI; Chung DR; Song JH; Peck KR
    Epidemiol Infect; 2018 Jul; 146(10):1326-1336. PubMed ID: 29781425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants.
    Ericson JE; Popoola VO; Smith PB; Benjamin DK; Fowler VG; Benjamin DK; Clark RH; Milstone AM
    JAMA Pediatr; 2015 Dec; 169(12):1105-11. PubMed ID: 26502073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for meticillin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgian university hospital.
    Libert M; Elkholti M; Massaut J; Karmali R; Mascart G; Cherifi S
    J Hosp Infect; 2008 Jan; 68(1):17-24. PubMed ID: 17942190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality.
    Robinson JO; Phillips M; Christiansen KJ; Pearson JC; Coombs GW; Murray RJ
    Clin Microbiol Infect; 2014 Jun; 20(6):530-5. PubMed ID: 24224545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.
    Li Z; Zhuang H; Wang G; Wang H; Dong Y
    BMC Infect Dis; 2021 Jan; 21(1):74. PubMed ID: 33446122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future strategies for treating Staphylococcus aureus bloodstream infections.
    Naber CK
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():26-34. PubMed ID: 18226087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.